Long-Term Assets: The sum of all assets classified as non-current.
Revelation Biosciences, Inc. (REVB) had Long-Term Assets of $0.84M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-8.69M |
|
-- |
|
-- |
|
$3.09M |
|
$-3.09M |
|
$0.08M |
|
$-3.01M |
|
$-3.01M |
|
$-3.01M |
|
$-3.01M |
|
$-3.01M |
|
$-3.01M |
|
$-3.09M |
|
$-3.09M |
|
3.21M |
|
3.21M |
|
$-2.71 |
|
$-2.71 |
|
| Balance Sheet Financials | |
$14.21M |
|
$0.14M |
|
|
Long-Term Assets |
$0.84M |
$15.04M |
|
$1.42M |
|
-- |
|
$0.64M |
|
$2.06M |
|
$12.99M |
|
$12.99M |
|
$12.99M |
|
3.91M |
|
| Cash Flow Statement Financials | |
$-3.21M |
|
$-0.07M |
|
$6.70M |
|
$10.70M |
|
$14.11M |
|
$3.41M |
|
$0.47M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
10.02 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-3.29M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-23.17% |
|
-23.17% |
|
-20.00% |
|
-23.17% |
|
$3.32 |
|
$-1.02 |
|
$-1.00 |
|